Emergence of SGLT2 Inhibitors as Powerful Antioxidants in Human Diseases

Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a new class of oral glucose-lowering agents. Apart from their glucose-lowering effects, large clinical trials assessing certain SGLT2 inhibitors have revealed cardiac and renal protective effects in non-diabetic patients. These excellent outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Kai-Fan, Chen, Yung-Lung, Chiou, Terry Ting-Yu, Chu, Tian-Huei, Li, Lung-Chih, Ng, Hwee-Yeong, Lee, Wen-Chin, Lee, Chien-Te
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388972/
https://www.ncbi.nlm.nih.gov/pubmed/34439414
http://dx.doi.org/10.3390/antiox10081166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388972/
https://www.ncbi.nlm.nih.gov/pubmed/34439414
http://dx.doi.org/10.3390/antiox10081166

Ejemplares similares